| Name
|
Urotensin II , human
|
| Code
|
[251293-28-4]
|
| The alias
|
Urotensin II , human
|
| Sequence (single letter abbreviation)
|
ETPDCFWKYCV (Cys5 and 10 bridge)
|
| Sequence (three-letter abbreviation)
|
H-Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val-OH (trifluoroacetate salt)(Cys5 and 10 bridge)
|
| A basic description
|
A cyclic peptide that has been discovered to be the endogenous ligand of an orphan GPCR and subsequently has been named the UT receptor. No synthetic ligands are available for investigating this novel peptide-receptor system.
|
| solubility
|
|
| The molecular weight
|
1388.59
|
| Chemical formula
|
C64H85N13O18S2
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
K.L.Ong et al., Cardiovasc. Drugs Ther., 19, 65 (2005)
R.S.Ames et al., Nature, 401, 282 (1999)
Y.Coulouarn et al., Proc. Natl. Acad. Sci. USA, 95, 15803 (1998)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Cys5 and 10 bridge)
|